Featured locations

Portugal - an emerging life sciences location

Portugal is an emerging life sciences market and an attractive location for pharma and medtech manufacturing
Table of Contents
In: Featured locations

The Portuguese pharmaceutical industry is not a major player on a pan-European scale. Valued in 2021 at around €3.8 billion (£3.3 billion), the domestic market accounts for 1.5 per cent of the European market, according to EFPIA.

R&D investment is low at €120 million (£103 million) and 0.3 per cent of European total. In terms of pharma employment, Portugal is ranked no.21 in Europe. The medtech industry is also modest in a European context. Portugal has one of the lowest employment rates (six persons per 10,000 inhabitants) in Europe and it is a net importer of medical devices with a negative trade balance of €837 million (£720 million).

Portugal has approximately 200 companies distributing medical products, primarily comprised of small or medium-sized companies employing, on average, 15 to 60 people.

Healthcare funding has been growing steadily

More from Life Sciences Real Estate

Stay on top of the life sciences real estate markets in Europe

Join us
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to Life Sciences Real Estate.
Your link has expired.
Success! Check your email for magic link to sign-in.
Success! Your billing info has been updated.
Your billing was not updated.